{"id":"https://openalex.org/W2000384318","doi":"https://doi.org/10.1111/j.1471-4159.1989.tb01852.x","title":"Binding Characteristics of t\u2010[35S]Butylbicyclophosphorothionate in Discrete Brain Regions of Rats Made Tolerant to and Dependent on Pentobarbital","display_name":"Binding Characteristics of t\u2010[35S]Butylbicyclophosphorothionate in Discrete Brain Regions of Rats Made Tolerant to and Dependent on Pentobarbital","publication_year":1989,"publication_date":"1989-04-01","ids":{"openalex":"https://openalex.org/W2000384318","doi":"https://doi.org/10.1111/j.1471-4159.1989.tb01852.x","mag":"2000384318","pmid":"https://pubmed.ncbi.nlm.nih.gov/2926391"},"language":"en","primary_location":{"id":"doi:10.1111/j.1471-4159.1989.tb01852.x","doi":"https://doi.org/10.1111/j.1471-4159.1989.tb01852.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1471-4159.1989.tb01852.x","pdf_url":null,"source":{"id":"https://openalex.org/S135837084","display_name":"Journal of Neurochemistry","issn_l":"0022-3042","issn":["0022-3042","1471-4159"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurochemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074545551","display_name":"Yoshihisa Ito","orcid":"https://orcid.org/0000-0002-1835-7783","observed_orcids":["https://orcid.org/0000-0002-1835-7783"]},"institutions":[{"id":"https://openalex.org/I29606459","display_name":"University of Mississippi Medical Center","ror":"https://ror.org/044pcn091","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I29606459","https://openalex.org/I4210141039"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yoshihisa Ito","raw_affiliation_strings":["Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson 39216","Department of Pharmacology and Toxicology The University of Mississippi Medical Center Jackson, Mississippi, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson 39216","institution_ids":["https://openalex.org/I29606459"]},{"raw_affiliation_string":"Department of Pharmacology and Toxicology The University of Mississippi Medical Center Jackson, Mississippi, U.S.A","institution_ids":["https://openalex.org/I29606459"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Paul A. Saunders","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I29606459","display_name":"University of Mississippi Medical Center","ror":"https://ror.org/044pcn091","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I29606459","https://openalex.org/I4210141039"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul A. Saunders","raw_affiliation_strings":["Department of Pharmacology and Toxicology, The University of Mississippi Medical Center, Jackson, Mississippi, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, The University of Mississippi Medical Center, Jackson, Mississippi, U.S.A","institution_ids":["https://openalex.org/I29606459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111782365","display_name":"Dong Koo Lim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I29606459","display_name":"University of Mississippi Medical Center","ror":"https://ror.org/044pcn091","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I29606459","https://openalex.org/I4210141039"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dong Koo Lim","raw_affiliation_strings":["Department of Pharmacology and Toxicology, The University of Mississippi Medical Center, Jackson, Mississippi, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, The University of Mississippi Medical Center, Jackson, Mississippi, U.S.A","institution_ids":["https://openalex.org/I29606459"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109947739","display_name":"Ing Kang Ho","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I29606459","display_name":"University of Mississippi Medical Center","ror":"https://ror.org/044pcn091","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I29606459","https://openalex.org/I4210141039"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ing K. Ho","raw_affiliation_strings":["Department of Pharmacology and Toxicology, The University of Mississippi Medical Center, Jackson, Mississippi, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, The University of Mississippi Medical Center, Jackson, Mississippi, U.S.A","institution_ids":["https://openalex.org/I29606459"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5109947739"],"corresponding_institution_ids":["https://openalex.org/I29606459"],"apc_list":{"value":5330,"currency":"USD","value_usd":5330},"apc_paid":null,"fwci":1.1328,"has_fulltext":false,"cited_by_count":23,"citation_normalized_percentile":{"value":0.73926516,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"52","issue":"4","first_page":"1093","last_page":"1098"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9092000126838684,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9092000126838684,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.02199999988079071,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.014600000344216824,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pentylenetetrazole-induced-seizures","display_name":"pentylenetetrazole-induced seizures","score":0.7580000162124634},{"id":"https://openalex.org/keywords/barbiturate-withdrawal","display_name":"barbiturate withdrawal","score":0.8059999942779541},{"id":"https://openalex.org/keywords/cerebellum","display_name":"cerebellum","score":0.9340000152587891},{"id":"https://openalex.org/keywords/frontal-cortex","display_name":"frontal cortex","score":0.9309999942779541},{"id":"https://openalex.org/keywords/substantia-nigra","display_name":"substantia nigra","score":0.9700000286102295},{"id":"https://openalex.org/keywords/striatum","display_name":"striatum","score":0.996999979019165},{"id":"https://openalex.org/keywords/benzodiazepine-receptor-binding","display_name":"benzodiazepine binding","score":0.652999997138977}],"concepts":[{"id":"https://openalex.org/C2776755955","wikidata":"https://www.wikidata.org/wiki/Q409632","display_name":"Pentobarbital","level":2,"score":0.8942394256591797},{"id":"https://openalex.org/C2780062018","wikidata":"https://www.wikidata.org/wiki/Q1319792","display_name":"Striatum","level":3,"score":0.61116623878479},{"id":"https://openalex.org/C2778900099","wikidata":"https://www.wikidata.org/wiki/Q5166679","display_name":"Convulsant","level":3,"score":0.5917624235153198},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5795997977256775},{"id":"https://openalex.org/C107824862","wikidata":"https://www.wikidata.org/wiki/Q616005","display_name":"Binding site","level":2,"score":0.46498793363571167},{"id":"https://openalex.org/C2776819090","wikidata":"https://www.wikidata.org/wiki/Q412391","display_name":"Pentylenetetrazol","level":4,"score":0.45751824975013733},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.4177383482456207},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4154580533504486},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3735354542732239},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3725961744785309},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.2831869125366211},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2674064636230469},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.25201281905174255},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2279285192489624},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.20963522791862488},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.1009332537651062},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.0},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001643","descriptor_name":"Bridged Bicyclo Compounds","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D001643","descriptor_name":"Bridged Bicyclo Compounds","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D001952","descriptor_name":"Bridged-Ring Compounds","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002531","descriptor_name":"Cerebellum","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004361","descriptor_name":"Drug Tolerance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005625","descriptor_name":"Frontal Lobe","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010424","descriptor_name":"Pentobarbital","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010433","descriptor_name":"Pentylenetetrazole","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011919","descriptor_name":"Rats, Inbred Strains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1471-4159.1989.tb01852.x","doi":"https://doi.org/10.1111/j.1471-4159.1989.tb01852.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1471-4159.1989.tb01852.x","pdf_url":null,"source":{"id":"https://openalex.org/S135837084","display_name":"Journal of Neurochemistry","issn_l":"0022-3042","issn":["0022-3042","1471-4159"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurochemistry","raw_type":"journal-article"},{"id":"pmid:2926391","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2926391","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of neurochemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[{"id":"https://openalex.org/G564312398","display_name":null,"funder_award_id":"DAO4480","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W597568034","https://openalex.org/W1684853394","https://openalex.org/W1755280605","https://openalex.org/W1775749144","https://openalex.org/W1819942908","https://openalex.org/W1895067531","https://openalex.org/W1966428196","https://openalex.org/W1969428610","https://openalex.org/W2011034301","https://openalex.org/W2013504695","https://openalex.org/W2026975402","https://openalex.org/W2029211053","https://openalex.org/W2039135452","https://openalex.org/W2042011980","https://openalex.org/W2042628413","https://openalex.org/W2056945518","https://openalex.org/W2058714039","https://openalex.org/W2063485560","https://openalex.org/W2065342750","https://openalex.org/W2079804893","https://openalex.org/W2087492545","https://openalex.org/W2093975375","https://openalex.org/W2134876647","https://openalex.org/W2264718498","https://openalex.org/W2265094805","https://openalex.org/W2424292640","https://openalex.org/W2470998733","https://openalex.org/W2982158931","https://openalex.org/W4406986087"],"related_works":["https://openalex.org/W1990067519","https://openalex.org/W2044399463","https://openalex.org/W1988890863","https://openalex.org/W2012575043","https://openalex.org/W2089370668","https://openalex.org/W2070650824","https://openalex.org/W2017473717","https://openalex.org/W2135304028","https://openalex.org/W2058217484","https://openalex.org/W2045452489"],"abstract_inverted_index":{"The":[0,49],"effects":[1],"of":[2,14,20,27,40,45,51,58,91,98,108,110,127,167,173,178,193,202],"acute":[3],"and":[4,86,139,155,158,206,210],"continuous":[5],"pentobarbital":[6,28,100,156,174,195],"administration":[7,26],"by":[8,115,226],"pellet":[9,153],"implantation":[10,154],"on":[11,232],"binding":[12,42,60,76,129,169,186,208,216],"characteristics":[13,77],"t-[35S]butylbicyclophosphorothionate":[15],"([35S]TBPS)":[16],"in":[17,43,65,74,78,105,134,144,163,214,228],"discrete":[18],"regions":[19,47,150],"rat":[21],"brains":[22],"were":[23,70],"examined.":[24],"Acute":[25],"(60":[29],"mg/kg,":[30,119],"s.c.)":[31],"affected":[32],"neither":[33],"the":[34,37,46,75,79,83,87,99,106,125,135,137,140,145,164,171,176,191,194,220],"KD":[35],"nor":[36],"Bmax":[38],"values":[39],"[35S]TBPS":[41,59,128,168,179,185,215],"any":[44],"studied.":[48],"cerebella":[50],"pentobarbital-tolerant":[52],"rats":[53,229],"had":[54],"an":[55],"increased":[56,133,189,221],"density":[57,126],"sites":[61,130,205,209],"with":[62],"no":[63,71,161],"change":[64],"their":[66],"apparent":[67,165],"affinity.":[68],"There":[69],"significant":[72,103],"changes":[73,162],"frontal":[80],"cortex":[81],"(FC),":[82],"striatum":[84],"(ST),":[85],"substantia":[88],"nigra":[89],"(SN)":[90],"these":[92,212],"animals.":[93],"Twenty-four":[94],"hours":[95],"after":[96],"removal":[97],"pellets,":[101],"a":[102],"decrease":[104],"latency":[107],"onset":[109],"first":[111],"twitch":[112],"response":[113],"induced":[114,225],"pentylenetetrazol":[116],"(PTZ)":[117],"(50":[118],"i.p.)":[120],"was":[121,131,187],"observed.":[122],"In":[123,147],"addition,":[124],"significantly":[132,188],"FC,":[136],"SN,":[138],"cerebellum":[141],"but":[142],"not":[143],"ST.":[146],"all":[148],"brain":[149],"studied,":[151],"placebo":[152],"tolerance":[157],"dependence":[159],"caused":[160],"affinity":[166],"or":[170],"IC50":[172],"for":[175],"inhibition":[177],"binding.":[180],"These":[181],"results":[182],"suggest":[183],"that":[184,211],"following":[190],"withdrawal":[192],"pellets":[196],"without":[197],"altering":[198],"intrinsic":[199],"coupling":[200],"activity":[201],"barbiturate":[203],"recognition":[204],"convulsant":[207],"increases":[213],"are":[217],"related":[218],"to":[219,223],"susceptibility":[222],"seizures":[224],"PTZ":[227],"made":[230],"dependent":[231],"pentobarbital.":[233]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}